Impaired Executive Control Is Associated with a Variation in the Promoter Region of the Tryptophan Hydroxylase 2 Gene

Current models of attention describe attention not as a homogenous entity but as a set of neural networks whose measurement yields a set of three endophenotypesalerting, orienting, and executive control. Previous findings revealed different neuroanatomical regions for these subsystems, and data from twin studies indicate differences in their heritability. The present study investigated the molecular genetic basis of attention in a sample of 100 healthy subjects. Attention performance was assessed with the attention network test that distinguishes alerting, orienting, and executive control (conflict) using a simple reaction time paradigm with different cues and congruent and incongruent flankers. Two gene loci on candidate genes for cognitive functioning, the functional catechol-O-methyltransferase (COMT) VAL158MET and the tryptophan hydroxylase 2 (TPH2) 703 G/T promoter polymorphism, were tested for possible associations with attention. COMT is involved in the catabolism of dopamine, and TPH is the rate-limiting enzyme for serotonin synthesis. Results showed no effect of the COMT polymorphism on attention performance. However, the TT genotype of TPH2 03 G/T was significantly associated with more errors (a possible indicator of impaired impulse control; p = .001) and with decreased performance in executive control (p = .001). This single-nucleotide polymorphism on the TPH2 gene explained more than 10% of the variance in both indicators of attention stressing the role of the serotonergic system for cognitive functions.

[1]  D. I. Boomsma,et al.  Genetic analysis of IQ, processing speed and stimulus-response incongruency effects , 2002, Biological Psychology.

[2]  T. Goldberg,et al.  Genes and the parsing of cognitive processes , 2004, Trends in Cognitive Sciences.

[3]  Alexander Strobel,et al.  Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. , 2007, The international journal of neuropsychopharmacology.

[4]  R. Oades.  Role of the serotonin system in ADHD: treatment implications , 2007, Expert review of neurotherapeutics.

[5]  M. Reuter,et al.  Identification of first candidate genes for creativity: A pilot study , 2006, Brain Research.

[6]  Dianne Currier,et al.  Stress, genes and the biology of suicidal behavior. , 2008, The Psychiatric clinics of North America.

[7]  M. Posner,et al.  Attentional networks , 1994, Trends in Neurosciences.

[8]  A. Malhotra,et al.  A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.

[9]  N L Segal,et al.  “Sources of Human Psychological Differences: The Minnesota Study of Twins Reared Apart” (1990), by , 2018 .

[10]  C. Fuchs,et al.  Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study , 2003, European Neuropsychopharmacology.

[11]  R. T. Constable,et al.  Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation , 2005, Journal of Neural Transmission.

[12]  M. Reuter,et al.  The influence of the dopaminergic system on cognitive functioning: A molecular genetic approach , 2005, Behavioural Brain Research.

[13]  U. Spampinato,et al.  5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and Striatum , 2002, Neuropsychopharmacology.

[14]  M. Egan,et al.  Effect of Catechol-O-Methyltransferase val158met Genotype on Attentional Control , 2005, The Journal of Neuroscience.

[15]  Martin Reuter,et al.  Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion , 2005, Neuroreport.

[16]  M. Reuter,et al.  Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[17]  G. Agam,et al.  Only tryptophan hydroxylase (TPH)‐2 is relevant to the CNS , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  M. Posner,et al.  Assessing the heritability of attentional networks , 2001, BMC Neuroscience.

[19]  Gerald L. Brown,et al.  A tryptophan hydroxylase gene marker for suicidality and alcoholism. , 1998, Archives of general psychiatry.

[20]  Philip D. Harvey.  Ziprasidone and cognition: the evolving story. , 2003, The Journal of clinical psychiatry.

[21]  J. Jolles,et al.  Effects of a novel method of acute tryptophan depletion on plasma tryptophan and cognitive performance in healthy volunteers , 2004, Psychopharmacology.

[22]  H. Nishimura,et al.  Late Developmental Stage-Specific Role of Tryptophan Hydroxylase 1 in Brain Serotonin Levels , 2006, The Journal of Neuroscience.

[23]  G. Mcclearn,et al.  No Association Between General Cognitive Ability and the A1 Allele of the D2 Dopamine Receptor Gene , 1997, Behavior genetics.

[24]  M. Posner,et al.  Assessing the molecular genetics of attention networks , 2002, BMC Neuroscience.

[25]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[26]  A. Battaglia,et al.  Possible association between autism and variants in the brain‐expressed tryptophan hydroxylase gene (TPH2) , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[27]  Eric Hahn,et al.  Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia , 2009, Psychiatry Research.

[28]  Jin Fan,et al.  The activation of attentional networks , 2005, NeuroImage.

[29]  K Konrad,et al.  Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder , 2005, Molecular Psychiatry.

[30]  J. Lieberman,et al.  Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia , 2002, Biological Psychiatry.

[31]  Martin Reuter,et al.  Molecular genetics support Gray's personality theory: the interaction of COMT and DRD2 polymorphisms predicts the behavioural approach system. , 2007, The international journal of neuropsychopharmacology.

[32]  Ian J. Deary,et al.  IQ, reaction time and the differentiation hypothesis , 2003 .

[33]  K. Lesch,et al.  Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. , 2000, Behavioral sciences & the law.

[34]  Jennifer M. Glass,et al.  Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene , 2006, Psychiatric genetics.

[35]  V. Golimbet.  Molecular genetic studies of cognitive deficit in schizophrenia , 2008, Molecular Biology.

[36]  Bruce D. McCandliss,et al.  Testing the Efficiency and Independence of Attentional Networks , 2002, Journal of Cognitive Neuroscience.

[37]  Jaap J. A. Denissen,et al.  Evolution, genes, and inter‐disciplinary personality research , 2007 .

[38]  Michael Bader,et al.  Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform , 2003, Science.

[39]  D. Goldman,et al.  Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. , 2005, Archives of general psychiatry.

[40]  P. Whitaker-Azmitia,et al.  Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits , 1997, Brain Research.

[41]  J. Nijenhuis,et al.  The correlation of g with attentional and perceptual-motor ability tests. , 2002 .

[42]  M. Posner,et al.  The attention system of the human brain. , 1990, Annual review of neuroscience.

[43]  M. Reuter,et al.  Two types of aggression are differentially related to serotonergic activity and the A779C TPH polymorphism. , 2005, Behavioral neuroscience.

[44]  Johannes Müller,et al.  Genetic Variation of Serotonin Function and Cognitive Control , 2007, Journal of Cognitive Neuroscience.

[45]  Martin Reuter,et al.  Association between a polymorphism in the promoter region of the TPH2 gene and the personality trait of harm avoidance. , 2007, The international journal of neuropsychopharmacology.

[46]  H. Möller,et al.  SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression , 2004, Molecular Psychiatry.

[47]  Brad E. Sheese,et al.  Executive Attention and Effortful Control: Linking Temperament, Brain Networks, and Genes , 2007 .

[48]  M. Posner,et al.  Mapping the genetic variation of executive attention onto brain activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Schmidt,et al.  Ecology and neurobiology of toxin avoidance and the paradox of drug reward , 2009, Neuroscience.

[50]  A. Jensen,et al.  The g factor , 1996, Nature.

[51]  S. Bowden,et al.  Confirmatory factor analysis of combined Wechsler Adult Intelligence Scale-Revised and Wechsler Memory Scale-Revised scores in a healthy community sample , 1999 .

[52]  Adam E. Green,et al.  Using genetic data in cognitive neuroscience: from growing pains to genuine insights , 2008, Nature Reviews Neuroscience.